EXOTHERA
0744.643.660 · rovalta.com · 23/09/2026
EXOTHERA
Company — Opening of bankruptcy.
Overview
What does EXOTHERA do?
EXOTHERA is a Public limited company incorporated in 2020. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Charleroi. It employs on average 139,2 ETP workers (FTE).
6040 Charleroi · Wallonie
Joint committees (2)
- 116
- 207
Trend over 3 financial years
| 2023 | 2022 | 2021 | |||
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 10 M € | +39.5% | 7,1 M € | +71.2% | 4,2 M € |
| EBITDA | -25,6 M € | -28.3% | -20 M € | -94.1% | -10,3 M € |
| Operating result | -30 M € | -35.8% | -22,1 M € | -102% | -10,9 M € |
| Net result | -31,4 M € | -36.5% | -23 M € | -101% | -11,4 M € |
| Balance sheet | |||||
| Equity | 4,6 M € | +22.2% | 3,8 M € | +36.3% | 2,8 M € |
| Total assets | 35,7 M € | +22.3% | 29,2 M € | +40.1% | 20,8 M € |
| Cash | 2,3 M € | +30.0% | 1,8 M € | +145% | 726,8 k € |
| Debts | 25,5 M € | +3.7% | 24,6 M € | +46.6% | 16,8 M € |
| Other | |||||
| Workforce | 139,2 ETP | +4.4% | 133,3 ETP | +58.7% | 84,0 ETP |
Board of directors
Seen on filing of 31/12/2023 · 9 active · 4 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
UNIVERCELLS● Bankrupt | 0502.742.288 |
UNIZIMA● Bankrupt | 0744.643.759 |
Financials
Full financial information
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2023 | 01/01/2022 | 01/01/2021 | 28/02/2020 |
| Closing of the financial year | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 11 months |
| Filing date | 04/07/2024 | 11/07/2023 | 22/07/2022 | 18/06/2021 |
| General meeting | 28/06/2024 | 30/06/2023 | 30/06/2022 | 17/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
4 filings with the NBB
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2023 · 9 active · 4 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Capital / shares27/01/2025CAPITAL, ACTIONS
- Mandates19/07/2024DEMISSIONS, NOMINATIONS
- Mandates22/02/2024CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
- Mandates18/09/2023DEMISSIONS, NOMINATIONS
- Capital / shares12/09/2023CAPITAL, ACTIONS
- Capital / shares22/11/2022CAPITAL, ACTIONS
- Capital / shares15/12/2021CAPITAL, ACTIONS
- Mandates11/08/2021DEMISSIONS, NOMINATIONS
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2023Annual accounts 2023-31,4 M €↓
- 2022Annual accounts 2022-23 M €↓
- 2021Annual accounts 2021-11,4 M €
- 02/03/2020IncorporationPublic limited company